Insmed Inc (STU:IM8N)
€ 67 0.5 (0.75%) Market Cap: 11.95 Bil Enterprise Value: 11.50 Bil PE Ratio: 0 PB Ratio: 25.75 GF Score: 63/100

Q2 2024 Insmed Inc Earnings Call Transcript

Aug 08, 2024 / 12:00PM GMT
Release Date Price: €63.5
Operator

Thank you for standing by. My name is John, and I'll be your conference operator for today. At this time, I would like to welcome everyone to the Insmed second quarter 2024 financial results call. (Operator Instructions)

Thank you. I would now like to turn the call over to Bryan Dunn, Head of Investor Relations. Please go ahead.

Bryan Dunn
Insmed Inc - Executive Director, Investor Relations

Thank you, John. Good day, everyone, and welcome to today's conference call to discuss Insmed's second quarter 2024 financial results and provide a business update. I am joined today by Will Lewis, Chair and Chief Executive Officer; and Sara Bonstein, Chief Financial Officer, who will each provide prepared remarks, after which they will be joined by Martina Flammer, Chief Medical Officer for the Q&A session.

Before we start, please note that today's call will include forward-looking statements based on our current expectations. These statements represent our judgment as of today and inherently involve risks and uncertainties that may cause actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot